These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 28348479)

  • 1. Non-alcoholic fatty liver disease connections with fat-free tissues: A focus on bone and skeletal muscle.
    Poggiogalle E; Donini LM; Lenzi A; Chiesa C; Pacifico L
    World J Gastroenterol; 2017 Mar; 23(10):1747-1757. PubMed ID: 28348479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel insights into the relationship between nonalcoholic fatty liver disease and osteoporosis.
    Filip R; Radzki RP; Bieńko M
    Clin Interv Aging; 2018; 13():1879-1891. PubMed ID: 30323574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Verification of the Nutritional and Dietary Factors Associated with Skeletal Muscle Index in Japanese Patients with Nonalcoholic Fatty Liver Disease.
    Himoto T; Miyatake K; Maeba T; Masaki T
    Can J Gastroenterol Hepatol; 2020; 2020():3576974. PubMed ID: 32695733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonalcoholic Fatty Liver Disease in The Rotterdam Study: About Muscle Mass, Sarcopenia, Fat Mass, and Fat Distribution.
    Alferink LJM; Trajanoska K; Erler NS; Schoufour JD; de Knegt RJ; Ikram MA; Janssen HLA; Franco OH; Metselaar HJ; Rivadeneira F; Darwish Murad S
    J Bone Miner Res; 2019 Jul; 34(7):1254-1263. PubMed ID: 31074909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influences of dietary vitamin D restriction on bone strength, body composition and muscle in rats fed a high-fat diet: involvement of mRNA expression of MyoD in skeletal muscle.
    Oku Y; Tanabe R; Nakaoka K; Yamada A; Noda S; Hoshino A; Haraikawa M; Goseki-Sone M
    J Nutr Biochem; 2016 Jun; 32():85-90. PubMed ID: 27142740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonalcoholic fatty liver disease in the over-60s: Impact of sarcopenia and obesity.
    Wijarnpreecha K; Panjawatanan P; Aby E; Ahmed A; Kim D
    Maturitas; 2019 Jun; 124():48-54. PubMed ID: 31097179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sarcopaenia is associated with NAFLD independently of obesity and insulin resistance: Nationwide surveys (KNHANES 2008-2011).
    Lee YH; Jung KS; Kim SU; Yoon HJ; Yun YJ; Lee BW; Kang ES; Han KH; Lee HC; Cha BS
    J Hepatol; 2015 Aug; 63(2):486-93. PubMed ID: 25772036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sarcopenia and fatty liver disease.
    Kim JA; Choi KM
    Hepatol Int; 2019 Nov; 13(6):674-687. PubMed ID: 31705444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between adipose tissue dysfunction, vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease.
    Cimini FA; Barchetta I; Carotti S; Bertoccini L; Baroni MG; Vespasiani-Gentilucci U; Cavallo MG; Morini S
    World J Gastroenterol; 2017 May; 23(19):3407-3417. PubMed ID: 28596677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone metabolism in non-alcoholic fatty liver disease: vitamin D status and bone mineral density.
    Eshraghian A
    Minerva Endocrinol; 2017 Jun; 42(2):164-172. PubMed ID: 27973461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: Nationwide surveys (KNHANES 2008-2011).
    Lee YH; Kim SU; Song K; Park JY; Kim DY; Ahn SH; Lee BW; Kang ES; Cha BS; Han KH
    Hepatology; 2016 Mar; 63(3):776-86. PubMed ID: 26638128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sarcopenia in patients with non-alcoholic fatty liver disease: is it a clinically significant entity?
    De Fré CH; De Fré MA; Kwanten WJ; Op de Beeck BJ; Van Gaal LF; Francque SM
    Obes Rev; 2019 Feb; 20(2):353-363. PubMed ID: 30474288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-Related Decrease in Skeletal Muscle Mass Is an Independent Risk Factor for Incident Nonalcoholic Fatty Liver Disease: A 10-Year Retrospective Cohort Study.
    Lee MJ; Kim EH; Bae SJ; Kim GA; Park SW; Choe J; Jung CH; Lee WJ; Kim HK
    Gut Liver; 2019 Jan; 13(1):67-76. PubMed ID: 30037166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between non-alcoholic fatty liver and skeletal muscle mass to visceral fat area ratio in women with type 2 diabetes.
    Su X; Xu J; Zheng C
    BMC Endocr Disord; 2019 Jul; 19(1):76. PubMed ID: 31315613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-alcoholic fatty liver disease-related fibrosis and sarcopenia: An altered liver-muscle crosstalk leading to increased mortality risk.
    Kuchay MS; Martínez-Montoro JI; Kaur P; Fernández-García JC; Ramos-Molina B
    Ageing Res Rev; 2022 Sep; 80():101696. PubMed ID: 35843589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissociation between exercise-induced reduction in liver fat and changes in hepatic and peripheral glucose homoeostasis in obese patients with non-alcoholic fatty liver disease.
    Cuthbertson DJ; Shojaee-Moradie F; Sprung VS; Jones H; Pugh CJ; Richardson P; Kemp GJ; Barrett M; Jackson NC; Thomas EL; Bell JD; Umpleby AM
    Clin Sci (Lond); 2016 Jan; 130(2):93-104. PubMed ID: 26424731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-Alcoholic Fatty Liver Disease and Bone Tissue Metabolism: Current Findings and Future Perspectives.
    Drapkina OM; Elkina AY; Sheptulina AF; Kiselev AR
    Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between sarcopenia and nonalcoholic fatty liver disease: the Korean Sarcopenic Obesity Study.
    Hong HC; Hwang SY; Choi HY; Yoo HJ; Seo JA; Kim SG; Kim NH; Baik SH; Choi DS; Choi KM
    Hepatology; 2014 May; 59(5):1772-8. PubMed ID: 23996808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonalcoholic fatty liver disease and decreased bone mineral density: is there a link?
    Targher G; Lonardo A; Rossini M
    J Endocrinol Invest; 2015 Aug; 38(8):817-25. PubMed ID: 26003827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review article: non-alcoholic fatty liver disease and osteoporosis--clinical and molecular crosstalk.
    Yilmaz Y
    Aliment Pharmacol Ther; 2012 Aug; 36(4):345-52. PubMed ID: 22730920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.